Home › Hidradenitis Suppurativa › New York
Hidradenitis Suppurativa clinical trials in New York
7 studies for Hidradenitis Suppurativa are looking for participants at sites in New York.
Cities in New York
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Cameron Dermatology, New York
- Icahn School Of Med At Mount Sinai, New York
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT07665437Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 5, New York
- Clinical Site 4, The Bronx
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07828860A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Equity Medical (LLC)- Site Number : 8400010, The Bronx
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US082, East Syracuse
- Investigative Site US034, New York
- Investigative Site US081, New York
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Dr Bobby Buka, Md Greenwich Village, New York
- Equity Medical, Llc, New York
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Sep 15, 2026 · NCT07049575A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Equity Medical, LLC, The Bronx
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 22, 2026 · NCT07384975A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Northwell Health Physician Partners, Lake Success
- Mount Sinai Doctors, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 6, 2026 · NCT07244263From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.